Genetic defects in cytolysis in macrophage activation syndrome.
about
Cytotoxic granule secretion by lymphocytes and its link to immune homeostasisPathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.Pro-inflammatory immune responses are associated with clinical signs and symptoms of human anaplasmosis.11-Month-Old Infant With Periodic Fevers, Recurrent Liver Dysfunction, and Perforin Gene Polymorphism.IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.Screening assays for primary haemophagocytic lymphohistiocytosis in children presenting with suspected macrophage activation syndromeEvaluation of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis: single center experience over a one-year period.Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in miceClinical features and correct diagnosis of macrophage activation syndrome.2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation CollInflammatory Gene Expression Profile and Defective Interferon-γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients.Macrophage activation syndrome in the era of biologic therapy.Hemophagocytic lymphohistiocytosis: an update for nephrologists.Kv1.3 channel blockade enhances the phagocytic function of RAW264.7 macrophages.Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities.Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab.How Viruses Contribute to the Pathogenesis of Hemophagocytic Lymphohistiocytosis.Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition.The influence of various therapeutic regimens on early clinical and laboratory response and outcome of children with secondary hemophagocytic lymphohistiocytosis.Novel UNC13D intronic variant disrupting a NFκB enhancer in a patient with recurrent macrophage activation syndrome and systemic juvenile idiopathic arthritis.Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.Laboratory parameters identify familial haemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosis
P2860
Q26776499-E9003544-144B-4FA0-8763-160E7D5213B4Q33439759-9881414F-5A66-4932-931E-84070D0EF996Q33442815-2D12E9DF-8E45-455F-8680-9F3EB921FEB1Q35674985-09DA3CE3-85BE-4AB8-B5EE-AD88619DA4E5Q35935473-EDCDB1B6-17EC-4A39-B704-8308BCEB4D08Q36287248-098DA654-9F60-42F2-AD31-7F38907DD27AQ36551787-B09A8289-F4F7-47D5-9765-FDB5169916F9Q36654557-D41FD632-E1A8-4FAB-8B71-8FC5F907BD53Q36655896-B907F877-84E9-4E47-B0C8-EE7B05C0A94CQ37019912-0D035D75-A2F9-42CF-83A7-315D79F93D72Q38530013-D5E7D8D7-9EE8-422E-8DDE-70A8427394F3Q38575277-47DD9A76-112A-4EA2-860C-9AB4A09C8EADQ38742750-F9676FD4-4616-41C8-BF62-AFFEB92ACBBCQ38786756-DA75460C-F52A-4158-B417-D111A7115547Q38813217-5D57FBF1-C53D-456E-841D-3120053D1F92Q38836515-04104721-93FE-46D9-A23D-0D29880562ADQ38855501-FF7074B3-35CA-4D00-9AAD-E38212839BF3Q40093291-D4094B54-08EF-459F-AFE7-17C4D37FEEFDQ41029387-15E3BA42-812B-4C57-855F-DB244F93878AQ41314439-B94E47D9-323E-4E1E-95C6-43A95DDEEABAQ47150341-B2C17107-BC80-4E56-A738-B9A9A5B30446Q49592363-01380E71-DA01-4ED0-80D9-85861CD5C750Q50159971-01ADBD28-F8B5-4F6C-938F-168C99C583AEQ51705351-0094EBD2-8AF1-4EA0-8AB1-87D58FB5CE21Q58412663-7F4E6D50-5677-469A-9CEA-0DCB0E352B23
P2860
Genetic defects in cytolysis in macrophage activation syndrome.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Genetic defects in cytolysis in macrophage activation syndrome.
@en
type
label
Genetic defects in cytolysis in macrophage activation syndrome.
@en
prefLabel
Genetic defects in cytolysis in macrophage activation syndrome.
@en
P2093
P2860
P1476
Genetic defects in cytolysis in macrophage activation syndrome
@en
P2093
Alexei A Grom
Bita Shakoory
Edward M Behrens
Mingce Zhang
T Prescott Atkinson
P2860
P2888
P356
10.1007/S11926-014-0439-2
P577
2014-01-01T00:00:00Z
P6179
1050583042